← Events of the day
New test could flag which men need aggressive prostate cancer treatment and which don't
🇺🇸 United States · Technology · 19 h ago
0 / 0 / 2
mentions in 1 / 6 / 24 h
0×
pace of the last 6 h vs the previous 18
26.10 10:40 UTC
first publication
Confirmed facts
Each fact is a sentence from a source that at least two independent outlets report.
Researchers at University College London (UCL) analyzed a tissue-based molecular test called Decipher to determine which men with high-risk prostate cancer were most likely to benefit from stronger treatment — and which might avoid unnecessary medication and side effects.
The findings were presented at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, held Oct.
Sarah Howlett of UCL Cancer Institute commented in a statement that for men with very high-risk prostate cancer , preventing spread of the disease is "critical.
Elai Davicioni, medical director of urology for Decipher test maker Veracyte, also commented, "We believe this growing evidence gives physicians a stronger reason to use Decipher before making decisions that can affect both cancer outcomes and patients’ quality of life .
Full evidence via the API
Facts with links, quotes, contradictions, unknowns, changes between versions and a suggested text length. On the Business plan there is a refined layer: Claude turns the sources into atomic facts with verbatim quotes and a short summary.
How it works
Pricing
Sources
The same group number means one site, one wire agency or a near-verbatim reprint: such articles count as one independent source.
Report an error